Navigation Links
Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
Date:5/23/2013

TOKIO, 22. Mai 2013 /PRNewswire/ -- Ranbaxy Laboratories Limited (im Weiteren Ranbaxy), eine Tochtergesellschaft von Daiichi Sankyo Co., Ltd. (im Weiteren Daiichi Sankyo), gab am 22. Mai die Maßnahmen bekannt, die Ranbaxy in den letzten Jahren ergriffen hat, um sich der Angelegenheiten der vorhergehenden Unternehmensführung anzunehmen.

(http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html).

Daiichi Sankyo unterstützt Ranbaxy weiterhin dabei, die Fehler der vorhergehenden Geschäftsführung zu korrigieren, welche zu Untersuchungen durch das Justizministerium der Vereinigten Staaten und die US-Arzneimittelzulassungsbehörde („USFDA") geführt hatten. Die Änderungen, die bei Ranbaxy vorgenommen werden sollen, umfassen die Geschäftsführung, die Unternehmenskultur, den Betrieb und die Compliance.

Daiichi Sankyo geht davon aus, dass bestimmte ehemalige Aktionäre von Ranbaxy wichtige Informationen hinsichtlich der Untersuchungen durch das US-Justizministerium und die FDA verschwiegen und falsch dargestellt haben. Daiichi Sankyo prüft derzeit die verfügbaren Rechtsmittel und kann das Thema nicht weiter kommentieren.

Informationen zu Daiichi Sankyo Co., Ltd. 
Börsennotierung: Börsenkürzel: 4568, Erster Index der Börsen in Tokio, Osaka und Nagoya
Präsident und CEO: Joji Nakayama

Kontakt: 
Noriaki Ishida 
Corporate Officer & Vice President 
Abteilung für Unternehmenskommunikation
Daiichi Sankyo Co., Ltd. 
Tel.: +81-3-6225-1126 
E-Mail: kondo.toshiya.cj@daiichisankyo.co.jp

http://www.daiichisankyo.com/


'/>"/>
SOURCE Daiichi Sankyo Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA
2. Ranbaxy Commends New IMS Study Which Credits Generic Prescription Drugs With $1 Trillion Savings In U.S. Health Care Costs Over Past 10 Years
3. Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
4. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
5. Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.
6. Indias Largest Generic Drugmaker Ranbaxy Pays $500 Million to Settle Systemic Generic Drug Manufacturing Fraud
7. Statement By Dinesh Thakur Regarding US Governments Case Against Ranbaxy
8. Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives
9. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
10. Simbionix kündigt Lizenzvertrag für chirurgische Videos an
11. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  The Senior Care Pharmacy ... Reform Committee Chairman Jason Chaffetz (R-UT) ... today,s hearing , "Developments in the Prescription ... and growing questions about abusive pharmacy benefit manager ... (R-UT) and Ranking Member Elijah Cummings (D-MD) are ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot ... 2015 Best in KLAS: Software & Services for HIT Implementation Support & Staffing ... report independently ranks vendor performance by healthcare executives, managers and clinicians representing over ...
(Date:2/5/2016)... ... ... Dr. Justin Scott and Dr. Lydia Muccioli of Pure Dental Health ... in need. The event is scheduled to take place on February 27, 2016 from ... dental care to community members in need. Each patient will be given the opportunity ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... founder of CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda ... CitiDent offers a complete range of oral health care, including general dentistry, cosmetic ...
(Date:2/5/2016)... , ... February 05, 2016 , ... In sleep, when ... as a dream. A hallmark feature of patients with eating disorders is significant self-criticism, ... eating disorder behaviors and obsessions are regarded as maladaptive means for coping with this ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... manufactures practical mobile kitchens, recently announced the debut of their latest mobile kitchen ... Mobile Kitchens provides organizations with modern, high-volume commercial kitchens for use anywhere in ...
Breaking Medicine News(10 mins):